Anjisheng biomedical technology (Guangzhou) Co., Ltd
安济盛
Anjisheng biomedical technology (Guangzhou) Co., Ltd
Biotech/Healthcare
Founded in June 2018 and based in Guangzhou Science City, Angitia Biopharmaceuticals (Guangzhou) is a multinational R&D company focused on novel drugs for musculoskeletal and joint diseases. Its founders and core team have extensive drug development and management experience at major multinational…
Latest round: Series D (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.